Makvandi, PooyanJosic, UrosDelfi, MasoudPinelli, FilippoJahed, VahidKaya, EmineTay, Franklin R.2024-05-252024-05-252021902198-384410.1002/advs.2020040142-s2.0-85100563173https://doi.org/10.1002/advs.202004014https://hdl.handle.net/20.500.14517/1581Jahed, Vahid/0000-0003-3834-9630; Kaya, Emine/0000-0002-9347-148X; Zarrabi, Ali/0000-0003-0391-1769; Makvandi, Pooyan/0000-0003-2456-0961; Ashrafizadeh, Milad/0000-0001-6605-822X; Zarepour, Atefeh/0000-0002-0347-5840; Nazarzadeh Zare, Ehsan/0000-0002-0446-4385; Agarwal, Tarun/0000-0002-3300-7781; Pinelli, Filippo/0000-0001-7356-3099; Ghomi, Matineh/0000-0002-5027-5358; Breschi, Lorenzo/0000-0001-7621-226X; JOSIC, UROS/0000-0001-5464-837XThe oral cavity and oropharynx are complex environments that are susceptible to physical, chemical, and microbiological insults. They are also common sites for pathological and cancerous changes. The effectiveness of conventional locally-administered medications against diseases affecting these oral milieus may be compromised by constant salivary flow. For systemically-administered medications, drug resistance and adverse side-effects are issues that need to be resolved. New strategies for drug delivery have been investigated over the last decade to overcome these obstacles. Synthesis of nanoparticle-containing agents that promote healing represents a quantum leap in ensuring safe, efficient drug delivery to the affected tissues. Micro/nanoencapsulants with unique structures and properties function as more favorable drug-release platforms than conventional treatment approaches. The present review provides an overview of newly-developed nanocarriers and discusses their potential applications and limitations in various fields of dentistry and oral medicine.eninfo:eu-repo/semantics/openAccessantibacterialantiviraldrug deliveryoral cancertissue regenerationReviewQ1Q188WOS:00061493100000133898183